Pricing Sign in

Role
Country
Date of registration
Address

Made In Tracker

Made In Tracker EasyUDI

Legal

Privacy Policy Legal Notice

About

About FAQ Contact

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

Organization name
UDI-DI code
Reference / catalog number

07350073850013 — Class IIa MDD by Polichem SA,…

MD Atlas
Polichem SA, Lussemburgo, succursale di Mendrisio

EUDAMED last updated this device on Jan 11, 2024

07350073850013

B-07350073850013

On the marketClass IIa

Applicable legislation: MDD [Directive 93/42/EEC on medical devices]
Organization name: Polichem SA, Lussemburgo, succursale di Mendrisio
UDI-DI code: 07350073850013
Reference / catalog number: 07350073850013

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Email

Password

No account yet?

Manufacturer information

Organization name: Polichem SA, Lussemburgo, succursale di Mendrisio
SRN: CH-MF-000025294
Manufacturer status: Active

Related devices

08430308132806B-08430308132806On the market Balneum Intensiv ® 10g (GB)B-08430308132790On the market Balneum Intensiv ® 500g (GB)B-08430308133292On the market Balneum Intensiv ® 50g (GB)B-08430308133308On the market 08430308132905B-08430308132905On the market

Certificates

No certificates registered for this manufacturer.

No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.

Critical warnings

1 warning recorded — scroll inside the panel to see all entries.

CW999
DO NOT USE VAGI-C If you are allergic (hypersensitive) to any of the components of the product. If you have or suspect to have a yeast vaginal infection (e.g. candidiasis) because the acidification of the vaginal pH may promote their proliferation. WARNINGS Keep out of the sight and reach of children. Do not swallow. Don’t store above 30ºC. Do not use broken tablets to avoid accidental injuries during insertion VAGI-C may contain small traces of bovine milk proteins.

Market distribution

Primary placement in Sweden; available across 1 country total.

Country	On market since	Until
SwedenPrimary placement		Still on market

Device identification

Trade name: not provided
UDI-DI code: 07350073850013
Basic UDI-DI: B-07350073850013
Reference / catalog number: 07350073850013
Issuing entity: GS1

Classification

Risk category: Class IIa
Applicable legislation: MDD [Directive 93/42/EEC on medical devices]
Status: On the market

Device details

Quantity: 1
Additional product description: —
Additional information URL: No additional information URL provided by the manufacturer.
Clinical sizes: No clinical sizes registered for this device.

EMDN nomenclature code(s)

U0803VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS

Compliance flags

Safety

Sterile

Single use

Contains latex

Reprocessed single-use

Direct marking

Substances

CMR substance

Endocrine disruptor

Regulatory

Annex XVI applicable

Sterilization

Lifecycle

New device

UDI-PI traceability

Batch number
Expiration date
Manufacturing date
Serial number
Software identification